Fri, June 6, 2025
Thu, June 5, 2025
Wed, June 4, 2025
Tue, June 3, 2025
Mon, June 2, 2025
Sun, June 1, 2025
Sat, May 31, 2025
Fri, May 30, 2025
Thu, May 29, 2025
Wed, May 28, 2025
Tue, May 27, 2025
Mon, May 26, 2025
Sun, May 25, 2025
Sat, May 24, 2025
Fri, May 23, 2025
Thu, May 22, 2025
Wed, May 21, 2025
Tue, May 20, 2025
[ Tue, May 20th ] - 13abc
Moment of Science: Cicadas
Mon, May 19, 2025
Sun, May 18, 2025
Sat, May 17, 2025
Fri, May 16, 2025
Thu, May 15, 2025
Wed, May 14, 2025
Tue, May 13, 2025
[ Tue, May 13th ] - WSAZ
Summer science experiments
Mon, May 12, 2025
Sun, May 11, 2025

A kidney disease showdown, and eye risk linked to GLP-1s


//science-technology.news-articles.net/content/2 .. ease-showdown-and-eye-risk-linked-to-glp-1s.html
Published in Science and Technology on by STAT   Print publication without navigation

And more biotech news brought to you by The Readout.

The article from STAT News dated June 6, 2025, discusses several key developments in the biotech industry. Otsuka and Vera Therapeutics have entered into a $1.8 billion deal to develop and commercialize treatments for kidney diseases, highlighting the growing focus on renal care. Additionally, the article covers the ongoing debate around GLP-1 drugs, with new data suggesting their potential in managing obesity and related conditions. The FDA's recent approval of the Elsa device for early detection of Alzheimer's disease marks a significant advancement in neurodegenerative diagnostics. Lastly, changes in Medicare Advantage plans are noted, which could impact coverage and costs for beneficiaries, reflecting broader shifts in healthcare policy and insurance.

Read the Full STAT Article at:
[ https://www.statnews.com/2025/06/06/biotech-news-otsuka-vera-therapeutics-glp-1-elsa-fda-medicare-advantage-the-readout/ ]

Publication Contributing Sources

Similar Science and Technology Publications